UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Of the Securities Exchange Act of 1934
Date of Report: October 31, 2023
Commission File Number: 001-36891
Cellectis S.A.
(Exact Name of registrant as specified in its charter)
8, rue de la Croix Jarry
75013 Paris, France
+33 1 81 69 16 00
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Cellectis S.A.
In connection with its Shareholders General Meeting (the Meeting) on June 27, 2023, Cellectis S.A. (the Company) adopted certain updates to the Companys Bylaws. Filed as Exhibit 99.1 hereto are Bylaws of the Company, updated as of June 27, 2023, restated to incorporate such updates.
This report on Form 6-K shall be deemed to be incorporated by reference in the Companys registration statements on Form F-3 (No. 333-265826) and Form S-8 (Nos. 333-204205, 333-214884, 333-222482, 333-227717, 333-258514, 333-267760 and 333-273777), to the extent not superseded by documents or reports subsequently filed.
EXHIBIT INDEX
| Exhibit | Title | |
| 99.1 | By-laws (statuts) of the registrant as of June 27, 2023 (English Translation). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CELLECTIS S.A | ||||||
| (Registrant) | ||||||
| Date: October 31, 2023 |
||||||
| By: | /s/ André Choulika | |||||
| Name: | André Choulika | |||||
| Title: | Chief Executive Officer | |||||